Franceschi, Enrico and Hofer, Silvia and Brandes, Alba A. and Frappaz, Didier and Kortmann, Rolf-Dieter and Bromberg, Jacoline and Dangouloff-Ros, Volodia and Boddaert, Nathalie and Hattingen, Elke and Wiestler, Benedikt and Clifford, Steven C. and Figarella-Branger, Dominique and Giangaspero, Felice and Haberler, Christine and Pietsch, Torsten and Pajtler, Kristian W. and Pfister, Stefan M. and Guzman, Raphael and Stummer, Walter and Combs, Stephanie E. and Seidel, Clemens and Beier, Dagmar and McCabe, Martin G. and Grotzer, Michael and Laigle-Donadey, Florence and Stucklin, Ana S. Guerreiro and Idbaih, Ahmed and Preusser, Matthias and van den Bent, Martin and Weller, Michael and Hau, Peter (2019) EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma. LANCET. ONCOLOGY, 20 (12). E715-E728. ISSN 1470-2045, 1474-5488
Full text not available from this repository. (Request a copy)Abstract
The European Association of Neuro-Oncology (EANO) and EUropean RAre CANcer (EURACAN) guideline provides recommendations for the diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma. The guideline is based on the 2016 WHO classification of tumours of the CNS and on scientific developments published since 1980. It aims to provide direction for diagnostic and management decisions, and for limiting unnecessary treatments and cost. In view of the scarcity of data in adults with medulloblastoma, we base our recommendations on adult data when possible, but also include recommendations derived from paediatric data if justified. Our recommendations are a resource for professionals involved in the management of post-pubertal and adult patients with medulloblastoma, for patients and caregivers, and for health-care providers in Europe. The implementation of this guideline requires multidisciplinary structures of care, and defined processes of diagnosis and treatment.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | CENTRAL-NERVOUS-SYSTEM; PRIMITIVE NEUROECTODERMAL TUMORS; CRANIOSPINAL RADIATION-THERAPY; STANDARD-RISK MEDULLOBLASTOMA; PROSPECTIVE RANDOMIZED-TRIAL; MOLECULAR SUBGROUPS; ADJUVANT CHEMOTHERAPY; PROGNOSTIC-FACTORS; PHASE-II; PEDIATRIC MEDULLOBLASTOMA; |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Neurologie |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 23 Mar 2020 08:08 |
| Last Modified: | 23 Mar 2020 08:08 |
| URI: | https://pred.uni-regensburg.de/id/eprint/25758 |
Actions (login required)
 |
View Item |
